Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2014 Jan 23;34(3):669–675. doi: 10.1161/ATVBAHA.113.303027

Table 4.

Baseline characteristics of the subjects according to obesity degree

NW (n=27) OW (n=20) OB (n=48)
BMI (Kg/m2) 23.0 (16.7–24.9) 26.7 (25.2–29.1)α 34.5 (30.0–54.7)αγ
Age (years) 36±15 45±14* 46±11α
Gender (W/M) 18/9 11/9 34/14
Waist circumf (cm) 78±11 95±7α 107±10αγ
TG (mmol/l) 1.0 (0.4–2.9) 1.8 (0.5–4.6)α 2.1 (1.0–5.6)α
Total-C (mmol/l) 4.7 (3.3–7.6) 6.2 (3.4–7.9)α 5.2 (3.6–8.1)
LDL-C (mmol/l) 2.8±1.1 4.1±1.2α 3.5±0.8α
HDL-C (mmol/l) 1.6±0.4 1.2±0.4α 1.0±0.2α
apoA-I (g/l) 1.8±0.4 1.6±0.3 1.4±0.2α
apoB-100 (g/l) 0.9±0.3 1.1±0.3* 1.0±0.3*
Glucose (mmol/l) 4.78 (3.9–5.4) 5.3 (4.4–6.6)α 5.5 (4.4–7.0)α
Insulin (pmol/l) 32.5 (13.9–66.7) 43.0 (13.9–147.2)α 76.4 (27.1–479.2)γ
HOMA-IR 0.9 (0.3–2.0) 1.4 (0.5–15.6)* 2.7 (0.9–20.6)αγ
TG/ HDL-C 1.5 (0.7–7.9) 3.6 (0.5–15.7) 4.4 (2.1–16.2)α
FFA(mmol/l) 0.5 (0.1–0.8) 0.6 (0.1–1.1) 0.6 (0.3–1.1)
Adiponectin (µg/ml) 12.6 (7.0–28.2) 7.3 (1.9–20.6)α 5.6 (1.9–16.4)α
hs-CRP (mg/l) 1.3(0.1–11.7) 2.3 (0.2–6.2) 3.4 (0.3–29.7)*

Data are expressed as mean±SD or median (range) for skewed distributed data. W indicates women; M, men; BMI, body mass index; Total-C, total cholesterol; HDL-C, high-density lipoprotein-cholesterol; LDL-C, low-density lipoprotein-cholesterol; apoA-I, apolipoprotein A-I; apoB, apolipoprotein B; HOMA-IR, homeostasis model assessment for insulin resistance index; FFA, free fatty acids; hs-CRP, high-sensitivity C-reactive protein. vs NW

*

p<0.05

α

p<0.01; vs OW

β

p<0.05

γ

p<0.01.